You Asked, We Answered: The Questions Every Benefits Pro Is Asking Right Now

Let's cut through the noise. Benefits professionals are busy, pharmacy is complicated, and you need straight answers to strategic questions. Not fluff. Not jargon. Just clear information about how member engagement works, how solutions integrate, and what ROI actually looks like. Below are the most important questions we're hearing from benefits pros like you — and the direct answers that help you evaluate what's right for your organization.

Q: Can Scripta work with a transparent PBM?

A: Absolutely. Scripta works seamlessly with transparent PBMs — in fact, our model complements theirs.

Transparent PBMs give employers visibility into what the plan is paying — the base cost of the drug plus any administrative or clinical fees. But even with that clarity, pharmacy costs can still feel confusing to members. Factors like plan design, formulary tiering, and deductible status all affect what employees actually pay at the counter.

That’s where Scripta comes in. We extend transparency to the member experience — showing employees what they’ll pay and how they can save before they fill their prescriptions.

Clients who work with transparent PBMs often see exceptional results with Scripta because both solutions share the same goal: clarity. Among clients who’ve partnered with us for at least two years, the average ROI is 10.5x, and every client that launched with a transparent PBM this year achieved a positive ROI within their first full quarter.

Together, transparent PBMs and Scripta make pharmacy pricing clear, actionable, and meaningful for both plans and members.

---

Q: We already have a lot of cost-saving programs. Why would we need Scripta in addition?

A: That’s great — and exactly why Scripta fits in so well.

Over the past few years, employers and consultants have become much more sophisticated in their approach to pharmacy savings — moving beyond rebates and AWP discounts to layer in clinical programs, new distribution models, and other innovative cost-saving strategies.

Think of everything you might already have in place: specialty coupon programs, GLP-1 management, discount-card wraps, or even onsite clinics. Each of these programs has real value — but only if members know how and when to use them.

That’s where Scripta comes in. We bridge the gap between the benefits you’ve built and the members who need them. Our technology helps employees understand their options and make confident, cost-effective decisions. Whether that means switching from a non-preferred brand to a preferred one or leveraging direct-from-manufacturer pricing and cash-pay options through partners like Mark Cuban’s Cost Plus Drugs, we help members take advantage of the programs you’ve invested in.

In short, Scripta helps your existing programs work smarter — ensuring members capture the savings opportunities available to them and helping you realize the full potential of your cost-containment strategy.

---

Q: Our members pretty much only listen to their doctors – so how does Scripta get through to them?

A: We hear this question often, and funnily enough, it usually comes from clients who end up seeing some of the strongest savings results. While members absolutely should listen to their doctors when it comes to their health, Scripta isn’t here to replace that relationship — we’re here to enhance it.

Scripta was founded by physicians who saw firsthand how much pricing confusion impacts patients’ decisions. Our mission is to make those doctor–patient conversations more informed and collaborative. We give members the tools and confidence to ask, “Is there a lower-cost alternative that would work just as well for me?”

When members receive a Scripta Savings Report, we encourage them to take it to their next appointment. Their physician still leads the care — Scripta simply helps ensure cost isn’t a barrier to following through on that care.

Doctors lead. We empower the conversation — helping patients make smarter, more affordable choices without sacrificing trust or quality.

---

Q: How does Scripta help clients stay ahead of market trends?

A: Most clients come to Scripta because they want to help members make smarter choices — to build awareness of lower-cost options, save money, and guide their members along the way. What they come to learn is that Scripta can do even more.

The pharmacy market evolves quickly — new exclusions, biosimilars, and breakthrough therapies can shift spend almost overnight. For most organizations, capitalizing on those trends requires time — formulary updates, plan changes, and long implementation cycles. Scripta bridges that gap.

Because our solution is flexible and data-driven, we can adapt to market changes in our system almost immediately. That means we can get the word out to members faster — helping plans take advantage of new savings opportunities the moment they arise.

In short, we don’t just help clients keep up with a changing market — we help them capitalize on it.

---

Q: How can employers manage skyrocketing GLP-1 costs?

A: GLP-1s have reshaped the pharmacy landscape almost overnight. With annual therapy costs exceeding $10,000 per member and expanding use beyond diabetes into weight management, most employers have had limited options to control spend. Until recently, the only real levers were exclusion or restriction — limiting who could access these medications, even when clinically appropriate.

That has now changed. Scripta teamed up with RxSaveCard so employers finally have a way to cover GLP-1s sustainably — not by saying no, but by paying smarter. By purchasing medications at transparent, direct-from-manufacturer pricing, plans can often fund GLP-1 therapy at a fraction of the PBM cost while maintaining clinical integrity and member satisfaction. We also work alongside clinical partners — such as digital metabolic or lifestyle programs — to help employers manage utilization responsibly while still supporting members who benefit most.

The result is a balanced strategy: employers reduce overall liability, members stay on the therapy that works for them, and everyone avoids the disruption that comes from blanket exclusions.